Takeda and Innovent have closed their global partnership for next-generation IO and ADC therapies after fulfilment of ...

Lupin has received US Food and Drug Administration (FDA) approval for Armlupeg (pegfilgrastim-unne) 6mg/0.6ml injection in a ...

Opinions amongst the CDC's ACIP were divided on the continued use of the hepatitis B vaccine in a paediatric population.

The strategic partnership sees two separate financial deals for the pair of oncology assets. Rights to Kelun’s integrin ...

Eisai has submitted a new drug application seeking approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for Leqembi’s (lecanemab) subcutaneous (SC) formulation (SC-AI) for early ...

By analyzing real-world data, digital health organizations can gain insights into actual costs, measure outcomes, and build ...

Eli Lilly and Company has received approval from the US FDA for the expanded use of Jaypirca tablets in 100mg and 50mg doses.

Høeg’s appointment to director of the FDA's CDER follows a turbulent period for the department, which has seen five leaders ...

The commissioners’ concerns are in response to sweeping vaccine regulation changes earmarked by CBER head Vinay Prasad.

Denali has entered a $275m royalty funding agreement with Royalty Pharma based on future net sales of tividenofusp alfa therapy.

Formosa Pharmaceuticals and Rxilient Medical have agreed on the commercialisation of APP13007 in ASEAN markets.

The pharma industry has called the IRA “price setting” and argues that the negotiations have not cut out-of-pocket costs for ...